Back
Day Range
$116.26
$119.85
52-Week Range
$92.52
$212.00
Volume
434,661
50D / 200D Avg
$144.78
/
$160.76
Prev Close
$118.14
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -86.1 | 0.3 |
| P/B | 25.1 | 2.9 |
| ROE % | -36.6 | 3.7 |
| Net Margin % | -6.0 | 3.8 |
| Rev Growth 5Y % | 23.3 | 10.0 |
| D/E | 4.8 | 0.2 |
Analyst Price Target
Hold
$210.91
+77.7%
Low: $184.00
High: $244.00
Forward EPS
-$0.32
Est. Revenue
880 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$2.40
$2.37 – $2.45
|
1.4 B | 1 |
| FY2028 |
$1.86
$1.57 – $2.38
|
1.2 B | 3 |
| FY2027 |
$0.83
$0.37 – $1.28
|
1 B | 8 |
Key Takeaways
Revenue grew 23.34% annually over 5 years — strong growth
Debt/Equity of 4.79 — high leverage
Generating 34.52M in free cash flow
Capital efficient — spends only 6.20% of revenue on capex
Growth
Revenue Growth (5Y)
23.34%
Revenue (1Y)26.24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-36.57%
ROIC-3.12%
Net Margin-5.96%
Op. Margin-4.93%
Safety
Debt / Equity
4.79
Current Ratio4.63
Interest Coverage-2.80
Valuation
P/E Ratio
-86.10
P/B Ratio25.11
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26.24% | Revenue Growth (3Y) | 23.15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 23.34% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 747.14M | Net Income (TTM) | -44.55M |
| ROE | -36.57% | ROA | -4.37% |
| Gross Margin | 70.57% | Operating Margin | -4.93% |
| Net Margin | -5.96% | Free Cash Flow (TTM) | 34.52M |
| ROIC | -3.12% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 4.79 | Current Ratio | 4.63 |
| Interest Coverage | -2.80 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -86.10 | P/B Ratio | 25.11 |
| P/S Ratio | 5.13 | PEG Ratio | 2.07 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.84B | Enterprise Value | 4.33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 747.14M | 591.84M | 492.68M | 410.92M | 322.83M |
| Net Income | -44.55M | -113.29M | -123.41M | -116.16M | -101.36M |
| EPS (Diluted) | -1.39 | -3.63 | -4.04 | -3.88 | -3.46 |
| Gross Profit | 527.25M | 407.53M | 331.81M | 281.63M | 213.57M |
| Operating Income | -36.81M | -115.51M | -125.16M | -113.78M | -99.94M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.02B | 931.45M | 433.14M | 448.22M | 462.97M |
| Total Liabilities | 867.30M | 840.54M | 223.05M | 208.41M | 183.45M |
| Shareholders' Equity | 152.75M | 90.91M | 210.10M | 239.81M | 279.52M |
| Total Debt | 731.18M | 736.91M | 129.82M | 131.04M | 117.71M |
| Cash & Equivalents | 236.01M | 419.60M | 36.17M | 78.83M | 127.56M |
| Current Assets | 702.77M | 645.82M | 230.81M | 288.77M | 305.52M |
| Current Liabilities | 151.89M | 110.92M | 107.37M | 89.10M | 87.85M |